Evidence map›Paper›PMID 20164824›Full record

ArticleKidney international2010

Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney.

Gilbert R Kinsey, Liping Huang, Amy L Vergis, Li Li, Mark D Okusa

Open access · bronzeAbstract read
In one paragraph

Article in Kidney international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 152 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Advances in Nano-Immunomodulatory Systems for the Treatment of Acute Kidney Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  5. Article
  6. Frontiers in cell and developmental biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Role of T cells in ischemic acute kidney injury and repair.The Korean journal of internal medicine · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gilbert R KinseyDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia Health System, Charlottesville, Virginia 22908, USA.
Liping Huang
Amy L Vergis
Li Li
Mark D Okusa
University of Virginia Health System · US

Funding

ROLE OF INFLAMMATION IN PULMONARY INJURYP01HL073361 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HEDRICK, CATHERINE C · 2004 to 2008
$8.0M
Sphingolipids in Acute Kidney Injury and Disease ProgressionR01DK085259 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2010 to 2023
$5.0M
Leukocyte Trafficking in Acute Renal FailureR01DK062324 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI OKUSA, MARK DOUGLAS · 2003 to 2016
$4.4M
Kidney Disease and InflammationT32DK072922 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2006 to 2020
$2.6M
ADENOSINE AND RENAL INJURYR01DK056223 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI OKUSA, MARK DOUGLAS · 2000 to 2009
$1.9M
Novel Adenosine A2A Agonists in Renal Tissue ProtectionR44DK058413 · NIDDK · ADENOSINE THERAPEUTICS, LLC · PI THOMPSON, ROBERT D · 2002 to 2003
$818k
NOVEL ADENOSINE 2A AGONISTS IN RENAL TISSUE PROTECTIONR41DK058413 · NIDDK · ADENOSINE THERAPEUTICS, LLC · PI OKUSA, MARK DOUGLAS · 2000 to 2000
$100k
Immune Mechanisms in Kidney Ischemic PreconditioningF32DK083185 · NIDDK · UNIVERSITY OF VIRGINIA · PI KINSEY, GILBERT R · 2009 to 2010
$59k
NHLBI NIH HHS P01HL07336NHLBI NIH HHS P01 HL073361NIDDK NIH HHS DK56223NIDDK NIH HHS DK58413NIDDK NIH HHS DK62324NIDDK NIH HHS F32 DK083185NIDDK NIH HHS F32DK083185NIDDK NIH HHS R01 DK056223NIDDK NIH HHS R01 DK062324NIDDK NIH HHS R01 DK085259NIDDK NIH HHS R41 DK058413NIDDK NIH HHS R44 DK058413NIDDK NIH HHS T32 DK072922NIDDK NIH HHS T32DK072922-01
6 · The paper itself

Abstract

Reperfusion following ischemia is associated with acute kidney injury and inflammation. Using a mouse model, we exposed the kidney to a nonlethal period of ischemia, rendering it refractory to future ischemia-induced dysfunction. This ischemic preconditioning is partially mediated by Treg lymphocytes that suppress immune responses. We found that this maneuver significantly inhibited the accumulation of neutrophils and macrophages, tubular necrosis, and loss of kidney function caused by a subsequent ischemia/reperfusion injury 1 week later. The initial ischemia/reperfusion caused a significant increase in CD4(+)CD25(+)FoxP3(+) and CD4(+)CD25(+)IL-10(+) Treg cells within the kidney at 7 days of reperfusion. Treatment of preconditioned mice with a Treg cell-depleting antibody (PC61) reversed the effect of preconditioning on kidney neutrophil accumulation and partially inhibited the functional and histological protection of preconditioning. Adoptive transfer of Treg cells in naive mice, before ischemia/reperfusion, mimicked the protective and anti-inflammatory effects of ischemic preconditioning on the kidney. These studies highlight the role of Treg cells in ischemic preconditioning.

Indexed as

Acute Kidney InjuryAdoptive TransferAnimalsInflammationInterleukin-10IschemiaIschemic PreconditioningKidneyMaleMiceMice, Inbred C57BLNeutrophilsReperfusion InjuryT-Lymphocytes, RegulatoryInterleukin-10

Identifiers

PMID20164824
PMCPMC2912287
OpenAlexW2004829396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.